Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics VI: Workshop on Celiac Disease

Online

A forum between stakeholders to discuss trial elements to facilitate drug development in celiac disease. The FDA is announcing a public workshop for celiac disease. Discussions will focus on the approach to drug development in celiac disease and include the following topic areas: • The histologic endpoints to assess treatment benefit in patients with celiac disease • Regulatory framework for ...